TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ame Bioscience AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,727
|
21,199
|
25,090 |
Financial expenses |
23
|
101
|
36 |
Earnings before taxes |
1,072
|
4,355
|
6,001 |
Total assets |
5,226
|
8,564
|
19,984 |
Current assets |
5,221
|
8,557
|
19,975 |
Current liabilities |
1,223
|
1,155
|
16,091 |
Equity capital |
4,003
|
7,409
|
3,892 |
- share capital |
99
|
106
|
103 |
Employees (average) | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
76.6%
|
86.5%
|
19.5% |
Turnover per employee | 5,727 | 25,090 | |
Profit as a percentage of turnover |
18.7%
|
20.5%
|
23.9% |
Return on assets (ROA) |
21.0%
|
52.0%
|
30.2% |
Current ratio |
426.9%
|
740.9%
|
124.1% |
Return on equity (ROE) |
26.8%
|
58.8%
|
154.2% |
Change turnover |
-14,067
|
-4,669
|
23,459 |
Change turnover % |
-71%
|
-18%
|
1439% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.